trending Market Intelligence /marketintelligence/en/news-insights/trending/ANTGtvQ21siMtuIVdDJk1A2 content esgSubNav
In This List

Resverlogix to undertake overnight marketed offering of units

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Commercial Banking Newsletter June Edition - 2022

Blog

Insight Weekly: US recession outlook; mortgage activity slowdown; climate disclosure push


Resverlogix to undertake overnight marketed offering of units

Resverlogix Corp. announced an overnight marketed offering of its common shares and common share purchase warrants.

The Canadian clinical stage biotechnology company has 105,701,543 common shares issued and outstanding.

The offering is led by Bloom Burton Securities Inc. on a best-efforts agency basis.

It is being made in every Canadian province, except Quebec, by way of a prospectus supplement to Resverlogix's base shelf prospectus dated Oct. 1, 2015.

The number and price of units to be distributed, and the exercise price and term of each whole common share purchase warrant will be determined in context of the market.